Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Biaryl purine derivatives as potent antiproliferative agents: inhibitors of cyclin dependent kinases. Part I.

Trova MP, Barnes KD, Barford C, Benanti T, Bielaska M, Burry L, Lehman JM, Murphy C, O'Grady H, Peace D, Salamone S, Smith J, Snider P, Toporowski J, Tregay S, Wilson A, Wyle M, Zheng X, Friedrich TD.

Bioorg Med Chem Lett. 2009 Dec 1;19(23):6608-12. doi: 10.1016/j.bmcl.2009.10.025. Epub 2009 Oct 12.

PMID:
19846305
2.

Cyclin-dependent kinase inhibitors inspired by roscovitine: purine bioisosteres.

Jorda R, Paruch K, Krystof V.

Curr Pharm Des. 2012;18(20):2974-80. Review.

PMID:
22571665
3.
4.

Design strategies, structure activity relationship and mechanistic insights for purines as kinase inhibitors.

Sharma S, Singh J, Ojha R, Singh H, Kaur M, Bedi PM, Nepali K.

Eur J Med Chem. 2016 Apr 13;112:298-346. doi: 10.1016/j.ejmech.2016.02.018. Epub 2016 Feb 11. Review.

PMID:
26907156
5.

Terpenyl-purines from the sea.

Gordaliza M.

Mar Drugs. 2009 Dec 23;7(4):833-49. doi: 10.3390/md7040833. Review.

6.

Discovery and development of Seliciclib. How systems biology approaches can lead to better drug performance.

Khalil HS, Mitev V, Vlaykova T, Cavicchi L, Zhelev N.

J Biotechnol. 2015 May 20;202:40-9. doi: 10.1016/j.jbiotec.2015.02.032. Epub 2015 Mar 6. Review.

7.

[Cell cycle and molecular targets: CDK inhibition].

Carassou P, Meijer L, Le Moulec S, Aoun J, Bengrine-Lefèvre L.

Bull Cancer. 2012 Feb 1;99(2):163-71. doi: 10.1684/bdc.2011.1383. Review. French.

8.

Inhibitors of Civ1 kinase belonging to 6-aminoaromatic-2-cyclohexyldiamino purine series as potent anti-fungal compounds.

Bordon-Pallier F, Jullian N, Ferrari P, Girard AM, Bocquel MT, Biton J, Bouquin N, Haesslein JL.

Biochim Biophys Acta. 2004 Mar 11;1697(1-2):211-23. Review.

PMID:
15023362

Supplemental Content

Support Center